KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Short-Term Debt issuances (2016 - 2026)

Medtronic's Short-Term Debt issuances history spans 13 years, with the latest figure at -$1.2 billion for Q1 2026.

  • For Q1 2026, Short-Term Debt issuances fell 22.53% year-over-year to -$1.2 billion; the TTM value through Jan 2026 reached $173.0 million, up 117.18%, while the annual FY2025 figure was -$1.1 billion, 199.72% down from the prior year.
  • Short-Term Debt issuances for Q1 2026 was -$1.2 billion at Medtronic, down from $753.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $1.9 billion in Q1 2023 and bottomed at -$1.2 billion in Q1 2026.
  • The 5-year median for Short-Term Debt issuances is $424.5 million (2022), against an average of $205.0 million.
  • The largest annual shift saw Short-Term Debt issuances crashed 224.8% in 2024 before it surged 204.01% in 2025.
  • A 5-year view of Short-Term Debt issuances shows it stood at $349.0 million in 2022, then surged by 135.24% to $821.0 million in 2023, then crashed by 32.16% to $557.0 million in 2024, then soared by 35.19% to $753.0 million in 2025, then crashed by 263.21% to -$1.2 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Short-Term Debt issuances are -$1.2 billion (Q1 2026), $753.0 million (Q4 2025), and $649.0 million (Q3 2025).